189 related articles for article (PubMed ID: 32795500)
1. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
[TBL] [Abstract][Full Text] [Related]
2. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.
Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K
Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786
[TBL] [Abstract][Full Text] [Related]
3. Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS.
Pajula K; Hyyryläinen J; Koistinen A; Leskinen JTT; Korhonen O
Eur J Pharm Biopharm; 2020 May; 150():43-49. PubMed ID: 32151730
[TBL] [Abstract][Full Text] [Related]
4. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
5. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
6. The contribution of Raman spectroscopy to the analysis of phase transformations in pharmaceutical compounds.
Hédoux A; Guinet Y; Descamps M
Int J Pharm; 2011 Sep; 417(1-2):17-31. PubMed ID: 21256937
[TBL] [Abstract][Full Text] [Related]
7. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
8. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
[TBL] [Abstract][Full Text] [Related]
10. DSC, FTIR and Raman Spectroscopy Coupled with Multivariate Analysis in a Study of Co-Crystals of Pharmaceutical Interest.
Garbacz P; Wesolowski M
Molecules; 2018 Aug; 23(9):. PubMed ID: 30149571
[TBL] [Abstract][Full Text] [Related]
11. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
Murdande SB; Pikal MJ; Shanker RM; Bogner RH
J Pharm Sci; 2010 Mar; 99(3):1254-64. PubMed ID: 19697391
[TBL] [Abstract][Full Text] [Related]
12. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
Forster A; Hempenstall J; Tucker ; Rades T
Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
[TBL] [Abstract][Full Text] [Related]
13. In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw extruder using Raman spectroscopy.
Saerens L; Ghanam D; Raemdonck C; Francois K; Manz J; Krüger R; Krüger S; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2014 Aug; 87(3):606-15. PubMed ID: 24657540
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time.
Martínez LM; Videa M; Sosa NG; Ramírez JH; Castro S
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983640
[TBL] [Abstract][Full Text] [Related]
15. Screening for differences in the amorphous state of indomethacin using multivariate visualization.
Savolainen M; Heinz A; Strachan C; Gordon KC; Yliruusi J; Rades T; Sandler N
Eur J Pharm Sci; 2007 Feb; 30(2):113-23. PubMed ID: 17169536
[TBL] [Abstract][Full Text] [Related]
16. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
[TBL] [Abstract][Full Text] [Related]
17. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
18. Solubility of pharmaceutical ingredients in triglycerides.
Brinkmann J; Huxoll F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
[TBL] [Abstract][Full Text] [Related]
19. Solid-Liquid Equilibrium in Co-Amorphous Systems: Experiment and Prediction.
Zemánková A; Hassouna F; Klajmon M; Fulem M
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985463
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
